Trusted Experts, Pioneering Research, Transforming Health
About Us
Founded in 2006, Omega Research is a premier research organization specializing in early- to late-stage industry sponsored clinical research trials. Headquartered in Debary, FL but with multiple locations across the southern US, our consortium of research sites allow us the unique opportunity to conduct clinical trials in all therapeutic areas while still maintaining that personal touch that is often missing in large institutions.
From feasibility to close out, we are committed to providing outstanding service that delivers timely and accurate data, well-qualified participants, high retention rates and personalized attention to ensure the success of the trial.
Adherence and compliance with international standards of Good Clinical Practice (GCP) and International Conference of Harmonization (ICH) are the foundation of our quality systems and standard operating procedures across all of our locations.
.jpeg)
Our Network of Providers
Omega Research partners with local specialists in fields like endocrinology, nephrology, gynecology, rheumatology, and internal medicine, giving us access to incredible databases of potential study subjects.
Our dedicated team of doctors, nurses, and health professionals strive to make every interaction positive, every single time. We are supported by full-time Regulatory Specialists, a Budget/Contract department, Nurse Practitioners, Physician Assistants, Registered Nurses, Medical Assistants, and Quality Assurance Specialists.
Our patient-focused research sites provide a memorable experience for our patients and colleagues alike, with comfortable spacious quarters and complimentary Wi-Fi.
Omega by the Numbers
277
Completed Clinical Trials
135
Years of Combined Experience
98.4%
Patient Retention Rate
28,000+
Patient Database
The 4 Phases of Research
PHASE 1
Purpose: Assess the safety of a new drug.
A small group (approximately 20 - 80) of healthy people will be given the investigational drug to:
-
Evaluate how the body handless the drug.
-
Assess safe dosage ranges.
-
Record any side effects.
PHASE 2
Purpose: Assess the safety and efficacy (how well something works) of a new drug.
A larger group of people with the disease being studies will be given the investigational drug to:
-
Determine effectiveness.
-
Continue to evaluate safely.
.
PHASE 3
Purpose: Assess the safety and efficacy of a new drug.
-
This phase helps confirm the effectiveness of the drug, gauge side effects and gather information so the drug or treatment can be used safely.
-
Hundreds or even thousands (300 - 3,000) of people may receive a new drug or treatment and be followed for several years.
PHASE 4
Purpose: Assess the safety and efficacy of a drug already on the market.
-
Researchers gather additional safety information on an even larger group of people.
-
Gather data on long-term effectiveness and affect on quality of life.
-
Evaluated for cost and against other similar drugs
*Information is gathered from City of Hope Infographic